Tag: NYSE:USNA

  • Drug Related Products: Natural Alternatives International (NASDAQ:NAII), ProPhase Labs Inc (NASDAQ:PRPH), USANA Health Sciences (NYSE:USNA), Auxilium Pharmaceuticals (NASDAQ:AUXL)

    On 4 JULY Natural Alternatives International, Inc. (NASDAQ:NAII) announced that the plaintiffs in four product liability suits have dismissed all of their claims against NAI relating to CarnoSyn® beta-alanine. Natural Alternatives International, Inc. (NASDAQ:NAII) net profit margin is 2.20% and weekly performance is -2.77%. On last trading day company shares ended up $5.27. Natural Alternatives International, Inc. (NASDAQ:NAII) distance from 50-day simple moving average (SMA50) is -7.28%.

    ProPhase Labs Inc (NASDAQ:PRPH) shares advanced 0.01% in last trading session and ended the day on $1.65. PRPH Gross Margin is 65.00% and its return on assets is -4.20%. ProPhase Labs Inc (NASDAQ:PRPH) quarterly performance is -13.61%.

    On 16 JUNE USANA Health Sciences, Inc. (NYSE:USNA) reported $1.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.30 by $0.15. The company had revenue of $182.40 million for the quarter, compared to the consensus estimate of $185.85 million. During the same quarter in the previous year, the company posted $1.28 earnings per share. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. Analysts expect that USANA Health Sciences will post $5.66 EPS for the current fiscal year. USANA Health Sciences, Inc. (NYSE:USNA) shares moved up 0.85% in last trading session and was closed at $78.46, while trading in range of $78.03 – $79.64. USANA Health Sciences, Inc. (NYSE:USNA) year to date (YTD) performance is 3.81%.

    On 26 JUNE Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) and QLT Inc. (NASDAQ: QLTI) announced that they have entered into a definitive agreement under which Auxilium plans to merge with QLT. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) ended the last trading day at $19.45. Company weekly volatility is calculated as 3.62% and price to cash ratio as 12.76. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) showed a negative weekly performance of -4.42%.